{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T06:20:50Z","timestamp":1778653250773,"version":"3.51.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.biopha.2016.10.017","type":"journal-article","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T16:45:47Z","timestamp":1476722747000},"page":"962-971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["6-Methoxyflavanone attenuates mechanical allodynia and vulvodynia in the streptozotocin-induced diabetic neuropathic pain"],"prefix":"10.1016","volume":"84","author":[{"given":"Shehla","family":"Akbar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fazal","family":"Subhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasiara","family":"Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisar","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gowhar","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wajahat","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khwaja","family":"Fawad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2016.10.017_bib0005","series-title":"Task Force on Taxonomy of the International Association for the Study of Pain. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definition of Pain Terms","first-page":"210","author":"Merskey","year":"1994"},{"key":"10.1016\/j.biopha.2016.10.017_bib0010","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.pain.2004.04.034","article-title":"Symptoms and signs in patients with suspected neuropathic pain","volume":"110","author":"Rasmussen","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2016.10.017_bib0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pain.2008.07.005","article-title":"Allodynia and hyperalgesia in diabetic rats are mediated by GABA and depletion of spinal potassium-chloride co-transporters","volume":"140","author":"Jolivalt","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2016.10.017_bib0020","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ncpneuro0504","article-title":"Diabetic neuropathy\u2014a review","volume":"3","author":"Said","year":"2007","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.biopha.2016.10.017_bib0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0074-7742(02)50078-7","article-title":"Potential mechanisms of neuropathic pain in diabetes","volume":"50","author":"Calcutt","year":"2002","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.biopha.2016.10.017_bib0030","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.neuropharm.2010.12.030","article-title":"GABA and central neuropathic pain following spinal cord injury","volume":"60","author":"Gwak","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2016.10.017_bib0035","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.2174\/1381612054865055","article-title":"Opioids in neuropathic pain","volume":"11","author":"Przewlocki","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2016.10.017_bib0040","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4103\/2230-8210.117193","article-title":"Vulvodynia: an unrecognized diabetic neuropathic syndrome","volume":"17","author":"Kalra","year":"2013","journal-title":"Indian J. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2016.10.017_bib0045","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00210-015-1145-y","article-title":"A streptozotocin-induced diabetic neuropathic pain model for static or dynamic mechanical allodynia and vulvodynia: validation using topical and systemic gabapentin","volume":"388","author":"Ali","year":"2015","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.biopha.2016.10.017_bib0050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12906-016-1048-6","article-title":"Passiflora incarnata attenuation of neuropathic allodynia and vulvodynia apropos GABA-ergic and opioidergic antinociceptive and behavioural mechanisms","volume":"16","author":"Aman","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2016.10.017_bib0055","first-page":"53","article-title":"Pharmacologic treatment of neuropathic pain","volume":"101","author":"Attal","year":"2001","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.biopha.2016.10.017_bib0060","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-0404.1999.tb07389.x","article-title":"Gabapentin: a new tool in the treatment of neuropathic pain","volume":"100","author":"Harden","year":"1999","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.biopha.2016.10.017_bib0065","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/sj.bjp.0706246","article-title":"Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells","volume":"145","author":"Kempuraj","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2016.10.017_bib0070","first-page":"461","article-title":"Anti-inflammatory, antioxidant and cytotoxic activities of flavonoids from Oxytropis falcata Bunge","volume":"8","author":"Dong","year":"2010","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.biopha.2016.10.017_bib0075","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0955-2863(02)00208-5","article-title":"Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships","volume":"13","author":"Heim","year":"2002","journal-title":"J. Nut. Biochem."},{"key":"10.1016\/j.biopha.2016.10.017_bib0080","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pnpbp.2007.07.023","article-title":"Behavioral effects of 6-bromoflavanone and 5-methoxy-6, 8-dibromoflavanone as anxiolytic compounds","volume":"32","author":"Ognibene","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiat."},{"key":"10.1016\/j.biopha.2016.10.017_bib0085","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.fct.2013.05.007","article-title":"Cognitive-enhancing effects of Rhus verniciflua bark extract and its active flavonoids with neuroprotective and anti-inflammatory activities","volume":"58","author":"Cho","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2016.10.017_bib0090","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jep.2013.12.003","article-title":"Antinociceptive and anti-inflammatory activities of extract and two isolated flavonoids of Carthamus tinctorius L","volume":"151","author":"Wang","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2016.10.017_bib0095","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature06493","article-title":"Reversal of pathological pain through specific spinal GABAA receptor subtypes","volume":"451","author":"Knabl","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2016.10.017_bib0100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuint.2015.07.013","article-title":"Flavonoid nutraceuticals and ionotropic receptors for the inhibitory neurotransmitter GABA","volume":"89","author":"Johnston","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2016.10.017_bib0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/bs.apha.2014.10.007","article-title":"Chapter seven-Interactions of flavonoids with ionotropic GABA receptors","volume":"72","author":"Hanrahan","year":"2015","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.biopha.2016.10.017_bib0110","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1007\/s11064-013-1157-2","article-title":"Modulation of ionotropic GABA receptors by 6-methoxyflavanone and 6-methoxyflavone","volume":"39","author":"Hall","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2016.10.017_bib0115","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1124\/jpet.108.146464","article-title":"Novel potent, and selective GABAC antagonists inhibit myopia development and facilitate learning and memory","volume":"328","author":"Chebib","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2016.10.017_bib0120","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0022-3565(25)09094-9","article-title":"The evaluation of the analgesic action of pethidine hydrochloride (Demerol)","volume":"80","author":"Woolfe","year":"1944","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2016.10.017_bib0125","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0304-3959(99)00111-6","article-title":"Detection of static and dynamic components of mechanical allodynia in rat models of neuropathic pain: are they signalled by distinct primary sensory neurones?","volume":"83","author":"Field","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2016.10.017_bib0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Meth."},{"key":"10.1016\/j.biopha.2016.10.017_bib0135","first-page":"29","article-title":"Determination of naringenin in rat plasma with the Culex\u00ae automated blood sampler coupled with liquid chromatography\/electrochemistry","volume":"4","author":"Xie","year":"2004","journal-title":"Asian J. Drug Metab. Pharmacokin."},{"key":"10.1016\/j.biopha.2016.10.017_bib0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.chroma.2006.01.019","article-title":"Analytical separation and detection methods for flavonoids","volume":"1112","author":"de Rijke","year":"2006","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.biopha.2016.10.017_bib0145","doi-asserted-by":"crossref","first-page":"e52323","DOI":"10.1371\/journal.pone.0052323","article-title":"A unified model of the GABA (A) receptor comprising agonist and benzodiazepine binding sites","volume":"8","author":"Bergmann","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2016.10.017_bib0150","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.biopha.2016.10.017_bib0155","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.biopha.2016.10.017_bib0160","doi-asserted-by":"crossref","first-page":"10161","DOI":"10.1074\/jbc.271.17.10161","article-title":"Role of aromatic transmembrane residues of the-opioid receptor in ligand recognition","volume":"271","author":"Befort","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2016.10.017_bib0165","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/bja\/aen088","article-title":"Spinal cord mechanisms of pain","volume":"101","author":"D'Mello","year":"2008","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.biopha.2016.10.017_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1054-3589(06)54001-3","article-title":"The role of GABA in the mediation and perception of pain","volume":"54","author":"Enna","year":"2006","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.biopha.2016.10.017_bib0175","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1523\/JNEUROSCI.22-15-06724.2002","article-title":"Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord","volume":"22","author":"Moore","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2016.10.017_bib0180","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/j.pain.0000000000000152","article-title":"Transplant-mediated enhancement of spinal cord GABAergic inhibition reverses paclitaxel-induced mechanical and heat hypersensitivity","volume":"156","author":"Br\u00e1z","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2016.10.017_bib0185","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000542-200205000-00020","article-title":"Spinal GABA (A) and GABA (B) receptor pharmacology in a rat model of neuropathic pain","volume":"96","author":"Malan","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.biopha.2016.10.017_bib0190","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1007\/s11064-014-1254-x","article-title":"GABA pharmacology: the search for analgesics","volume":"39","author":"McCarson","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2016.10.017_bib0195","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neuint.2011.11.006","article-title":"Decreased intracellular GABA levels contribute to spinal cord stimulation-induced analgesia in rats suffering from painful peripheral neuropathy: the role of KCC2 and GABA A receptor-mediated inhibition","volume":"60","author":"Janssen","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2016.10.017_bib0200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0304-3959(96)03249-6","article-title":"The effect of spinal GABA receptor agonists on tactile allodynia in a surgically-induced neuropathic pain model in the rat","volume":"70","author":"Hwang","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2016.10.017_bib0205","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.tips.2009.06.004","article-title":"Developing analgesics by enhancing spinal inhibition after injury: GABA A receptor subtypes as novel targets","volume":"30","author":"Munro","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2016.10.017_bib0210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4196\/kjpp.2010.14.2.59","article-title":"Are spinal GABAergic elements related to the manifestation of neuropathic pain in rat?","volume":"14","author":"Lee","year":"2010","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2016.10.017_bib0215","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/bcpt.12017","article-title":"Antihyperalgesic effect of the GABAA ligand clobazam in a neuropathic pain model in mice: a pharmacokinetic\u2013pharmacodynamic study","volume":"112","author":"Besson","year":"2013","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2016.10.017_bib0220","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0304-3959(00)00404-8","article-title":"The effects of GABA B agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat","volume":"90","author":"Patel","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2016.10.017_bib0225","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.2337\/db13-1158","article-title":"Location, location location? Is the pain of diabetic neuropathy generated by hyperactive sensory neurons?","volume":"62","author":"Calcutt","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2016.10.017_bib0230","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1017\/S0140525X97261480","article-title":"Central inhibitory dysfunctions: mechanisms and clinical implications","volume":"20","author":"Wiesenfeld-Hallin","year":"1997","journal-title":"Behav. Brain Sci."},{"key":"10.1016\/j.biopha.2016.10.017_bib0235","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0304-3959(96)03249-6","article-title":"The effect of spinal GABA receptor agonists on tactile allodynia in a surgically-induced neuropathic pain model in the rat","volume":"70","author":"Hyun Hwang","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2016.10.017_bib0240","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/(SICI)1098-2299(199806\/07)44:2\/3<106::AID-DDR8>3.0.CO;2-Q","article-title":"An evaluation of the GABA uptake blocker tiagabine in animal models of neuropathic and nociceptive pain","volume":"44","author":"Giardina","year":"1998","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.biopha.2016.10.017_bib0245","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1124\/jpet.104.081778","article-title":"Comparison of the antinociceptive profiles of gabapentin and 3-methylgabapentin in rat models of acute and persistent pain: implications for mechanism of action","volume":"313","author":"Urban","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2016.10.017_bib0250","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0304-3959(93)90224-D","article-title":"Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic pain","volume":"53","author":"Desmeules","year":"1993","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2016.10.017_bib0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpain.2005.10.007","article-title":"Efficacy of mu-opioid agonists in the treatment of evoked neuropathic pain: systematic review of randomized controlled trials","volume":"10","author":"Eisenberg","year":"2006","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.biopha.2016.10.017_bib0260","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.pain.2008.01.004","article-title":"Peripherally acting mu-opioid receptor agonist attenuates neuropathic pain in rats after L5 spinal nerve injury","volume":"138","author":"Guan","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2016.10.017_bib0265","article-title":"Current concepts in vulvodynia with a focus on pathogenesis and pain mechanisms","author":"Thornton","year":"2015","journal-title":"Aust. J. Dermatol."},{"key":"10.1016\/j.biopha.2016.10.017_bib0270","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/AJP.0b013e31821c98ec","article-title":"Altered central sensitization in subgroups of women with vulvodynia","volume":"27","author":"Zhang","year":"2011","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.biopha.2016.10.017_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ddr.430030102","article-title":"Central GABA-ergic systems and analgesia","volume":"3","author":"DeFeudis","year":"1983","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.biopha.2016.10.017_bib0280","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0024-3205(85)90645-9","article-title":"GABA in morphine analgesia and tolerance","volume":"37","author":"Sivam","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2016.10.017_bib0285","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0278-5846(84)90018-6","article-title":"GABAergic mechanisms in antinociception: Prog","volume":"8","author":"Sawynok","year":"1984","journal-title":"Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2016.10.017_bib0290","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1517\/17460441.3.6.677","article-title":"Strategies to assess blood-brain barrier penetration","volume":"3","author":"Di","year":"2008","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.biopha.2016.10.017_bib0295","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.neuroimage.2004.01.046","article-title":"Brainstem involvement in the initial response to pain","volume":"22","author":"Petrovic","year":"2004","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopha.2016.10.017_bib0300","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1523\/JNEUROSCI.21-14-05281.2001","article-title":"Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the \u03bc-opioid receptor","volume":"21","author":"Porreca","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2016.10.017_bib0305","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/brain\/awn330","article-title":"Neuropathic pain is maintained by brainstem neurons co-expressing opioid and cholecystokinin receptors","volume":"132","author":"Zhang","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2016.10.017_bib0310","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13041-014-0072-z","article-title":"Sensitization of neurons in the central nucleus of the amygdala via the decreased GABAergic inhibition contributes to the development of neuropathic pain-related anxiety-like behaviors in rats","volume":"7","author":"Jiang","year":"2014","journal-title":"Mol. Brain"},{"key":"10.1016\/j.biopha.2016.10.017_bib0315","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/aps.2008.14","article-title":"Cerebral cortex modulation of pain","volume":"30","author":"Xie","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2016.10.017_bib0320","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00018-004-4283-9","article-title":"Cortical modulation of pain","volume":"62","author":"Ohara","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2016.10.017_bib0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2012.01.017","article-title":"Emerging drug targets for pain treatment","volume":"681","author":"Li","year":"2012","journal-title":"Eur. J. Pharmacol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216308587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216308587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:34:45Z","timestamp":1773873285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216308587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":65,"alternative-id":["S0753332216308587"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2016.10.017","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"6-Methoxyflavanone attenuates mechanical allodynia and vulvodynia in the streptozotocin-induced diabetic neuropathic pain","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2016.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}